Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Expert Opinion on Drug Discovery|July 12, 2025
Designing drugs against leishmaniasis: is targeting the sterol biosynthesis pathway the answer?Gonzalo Visbal, Maribel Navarro
Journal of Inorganic Biochemistry|January 1, 2008
Synthesis and characterization of platinum-sterol hydrazone complexes with biological activity against Leishmania (L.) mexicanaGonzalo Visbal, Edgar Marchán, Alexis Maldonado, et al.
ACS Omega|February 3, 2025
Zinc from an Essential Element to an Antiparasitic Therapeutic AgentMaribel Navarro, Luana Vanessa Daniel, Legna Colina-Vegas, et al.
Molecular and Biochemical Parasitology|December 7, 2002
Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicanaJulio A Urbina, Juan Luis Concepcion, Salomé Rangel, et al.
Current Pharmaceutical Design|November 13, 2020
Metallodrugs for the Treatment of Trypanosomatid Diseases: Recent Advances and New InsightsMaribel Navarro, Rodrigo M S Justo, Giset Y Sánchez Delgado, et al.
Investigacion Clinica|April 25, 2012
[In vitro synergisms among hydrazones, ajoeno and posaconazole against Cryptococcus spp]Julio Vivas, Primavera Alvarado, Gonzalo Visbal, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 26, 2011
Two squalene synthase inhibitors, E5700 and ER-119884, interfere with cellular proliferation and induce ultrastructural and lipid profile alterations in a Candida tropicalis strain resistant to fluconazole, itraconazole, and amphotericin BKelly Ishida, Gonzalo Visbal, Juliany Cola Fernandes Rodrigues, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2009
Amiodarone destabilizes intracellular Ca2+ homeostasis and biosynthesis of sterols in Leishmania mexicanaXenón Serrano-Martín, Yael García-Marchan, Alexis Fernandez, et al.
Pageof 3